VM
Vaibhav Mahadeorao Giri
About Vaibhav Mahadeorao Giri
Data last updated:
Vaibhav Mahadeorao Giri is a Director at Dux Ducis Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Dux Ducis Pharmaceuticals Private Limited reported revenue of ₹4.5 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dux Ducis Pharmaceuticals Private Limited U51101MH2014PTC254173 | Director | 12 Mar 2014 | 2014 | ₹4.5 Lakh (FY 2019) | Active |
Board colleagues of Vaibhav Mahadeorao Giri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anuradha Shridhar Giri | 07030600 | Dux Ducis Pharmaceuticals Private Limited | Director |
| Prashant Rupchand Pakhidde | 07941152 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Vaibhav Himatrao Pande | 08279066 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Vivekanand Sudhakar Manwatkar | 07941233 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Yogesh Subhash Kanchalwar | 08293775 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vaibhav Mahadeorao Giri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaibhav Mahadeorao Giri
Vaibhav Mahadeorao Giri currently holds 1 directorship: Dux Ducis Pharmaceuticals Private Limited (Director, since 12 Mar 2014, revenue ₹4.5 Lakh (FY 2019)).
Vaibhav Mahadeorao Giri was first appointed on 12 Mar 2014 as Director at Dux Ducis Pharmaceuticals Private Limited.
The current boards of Vaibhav Mahadeorao Giri's companies include Anuradha Shridhar Giri (Dux Ducis Pharmaceuticals Private Limited), Prashant Rupchand Pakhidde (Dux Ducis Pharmaceuticals Private Limited), Vaibhav Himatrao Pande (Dux Ducis Pharmaceuticals Private Limited), Vivekanand Sudhakar Manwatkar (Dux Ducis Pharmaceuticals Private Limited), Yogesh Subhash Kanchalwar (Dux Ducis Pharmaceuticals Private Limited).